-
Oncology R&D
08 Jul 2025 20:21 GMT
… approach to non-small cell lung cancer by targeting the biomarker c … ’s groundbreaking breast, gastric and lung cancer drug Enhertu is paving the … taking Roche’s monoclonal antibody Herceptin for a HER2-positive tumor …
-
Proposal To Fund Medicines For Lung Cancer, Breast Cancer And Respiratory Conditions
13 Sep 2024 00:42 GMT
… of advanced non-small-cell lung
cancer:
as a first treatment option …
since the emergence of trastuzumab (Herceptin) 20 years
ago."
Chair … .
Proposal
to fund treatments for lung cancer, breast cancer and
respiratory
conditions …
-
Revisit Every OncLive On Air Episode From June 2025
01 Jul 2025 21:03 GMT
… -type advanced non–small cell lung cancer (NSCLC). He also highlighted the … ) vs induction taxane plus trastuzumab (Herceptin) and pertuzumab (THP) in patients …
-
Expert Investigators Highlight Cross-Cancer Updates for Fellows From the 2025 AACR Annual Meeting
01 Jul 2025 14:33 GMT
… Make a Splash in Lung Cancer
During the AACR Annual … patients with non–small cell lung cancer (NSCLC). In the … , director of the Jilin Lung Cancer Diagnosis and Treatment Centre in … evaluated in combination with trastuzumab (Herceptin) in patients with HER2- …
-
Biosimilars Market Size to Hit $76.2 Billion by 2030 - Driving Value-Based Care for Drugmakers, Regulators & Emerging Markets | The Research Insights
01 Jul 2025 14:48 GMT
… as Humira (adalimumab), Remicade (infliximab), Herceptin (trastuzumab), Enbrel (etanercept), etc., have … mesothelioma, melanoma, non-small cell lung cancer, and renal cell carcinoma.
In …
-
[Latest] Global Lung Tumor Market Size/Share Worth USD 46.3 Billion by 2033 at a 7.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
15 Apr 2024 16:30 GMT
… lung tumor diagnosis. This delay could result in the diagnosis of lung tumors … Related Reports: Lung Cancer Liquid Biopsy Market: Lung Cancer Liquid Biopsy … (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), …
-
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
22 Feb 2024 14:19 GMT
… lung cancer, precision oncology has achieved notable advances. Lung cancer … ; Genentech), trastuzumab (Herceptin; Genentech), T-DM1 … Lung Cancer: From Broad Treatment to Individualized Approaches
Lung cancer … Immunotherapy in lung cancer. Transl Lung Cancer Res. …
-
Lung Cancer Surgery Market Worth USD 7.8 billion by 2030, Trends Analysis, Growth Rate, Share, Size, Revenue, Opportunities, Challenges, Key Drivers, Instrument, Procedure, Volume Data, Forecasts 2023-2030 | Exclusive Report by Delvens
15 May 2023 14:35 GMT
… of diagnosing and treating lung cancer Therapies for lung cancer can be broadly categorised … ;CAS9, Others), Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade …
-
Breast Cancer and the Use of Predictive Genomics
18 Jun 2025 16:10 GMT
… in the United States, behind lung cancer.3 When breast cancer is … HER2+ breast cancer are trastuzumab (Herceptin), pertuzumab (Perjeta), and lapatinib (Tykerb …
-
Boryung's licensed-in lung cancer drug wins approval in Korea
27 Sep 2022 04:43 GMT
… : lurbinectedin), a small cell lung cancer (SCLC) drug licensed-in … for Zepzelca, a small cell lung cancer (SCLC) drug.
Under … faster than non-small cell lung cancer (NSCLC). SCLC also … and Samfenet, a biosimilar referencing Herceptin, in December.
This year …
About
© 1995-2025